Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017

Alethia Young Maintained (ASND) at Buy with Increased Target to $50 on, Sep 22nd, 2017

Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $30 to $50 on, Sep 22nd, 2017.

Alethia, nor any peers, have made any analyst calls on ASND in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30